Eczematous reaction to hepatitis B vaccine

Contact Dermatitis

Volumn 40, Issue 3, 1999, Pages 158-159

  McKenna, K E ^a  

^a Royal Victoria Hospitals Trust   (United Kingdom)

Author keywords

Adverse drug reactions; Allergic contact dermatitis; Hepatitis B vaccine; Medicaments; Thimerosal

Indexed keywords

CORTICOSTEROID; HEPATITIS B VACCINE; THIOMERSAL;

ADULT; ARTICLE; CASE REPORT; ECZEMA; FEMALE; HISTOPATHOLOGY; HUMAN; PATCH TEST; TOPICAL DRUG ADMINISTRATION;

EID: 0033065291     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0536.1999.tb06015.x     Document Type: Article

References (19)

1. Aubin F, Angonin R, Humbert P, Agache P. Lichen planus following hepatitis B vaccination. Arch Dermatol 1994: 130: 1329-1330.
2. Daoud M S, Dicken C H. Anetoderma after hepatitis B immunization in two siblings. J Am Acad Dermatol 1997: 36: 779-780.
3. Di Lernia V, Lo Scocco G, Bisighini G. Erythema multiforme following hepatitis B vaccine. Ped Dermatol 1994: 11: 363-364.
4. Guiserix J. Systemic lupus erythematosus following hepatitis B vaccine. Nephron 1996: 74: 441.
5. Castresana-Isla C J, Herrera-Martinez G, Vega-Molina J. Erythema nodosum and Takayasu's arteritis after immunization with plasma derived hepatitis B vaccine. J Rheumatol 1993: 20: 1417-1418.
6. Rietschel R L, Adams R M. Reactions to thimerosal in hepatitis B vaccines. Dermatol Clin 1990: 8: 161-164.
7. Cox N H, Forsyth A. Thimerosal allergy and vaccination reactions. Contact Dermatitis 1988: 18: 229-233.
8. Forström L, Hannuksela M, Kousa M, Lehmuskallio E. Merthiolate hypersensitivity and vaccination. Contact Dermatitis 1980: 6: 241-245.
9. Tosti A, Melino M, Bardazzi F. Systemic reactions due to thimerosal. Contact Dermatitis 1986: 15: 187-188.
10. Lohiya G. Asthma and urticaria after hepatitis B vaccination. West J Med 1987: 147: 341.
11. Maibach H. Acute laryngeal obstruction presumed secondary to thimerosal (merthiolate) delayed hypersensitivity. Contact Dermatitis 1975: 1: 221.
12. Möller H. Merthiolate allergy: a nationwide iatrogenic sensitization. Acta Dermato-venereologica 1977: 57: 509-517.
13. Sato M. Patch test of mercury compounds and disinfectant solutions on clinical picture of mercury contact dermatitis. Jpn J Dermatol 1989: 99: 15-23.
14. Osawa J, Kitamura K, Ikezawa Z, Nakajima H. A probable role for vaccines containing thimerosal in thimerosal hypersensitivity. Contact Dermatitis 1991: 24: 178-182.
15. Hansson J, Möller H. Patch test reactions to merthiolate in healthy young subjects. Br J Dermatol 1976: 83: 349-356.
16. Möller H. Why thimerosal allergy? Int J Dermatol 1980: 19: 29.
17. Takino C. Clinical study of contact dermatitis induced by thimerosal. Rinpi 1971: 25: 1175-1180.
18. Gonçalo M, Figueiredo A, Gonçalo S. Hypersensitivity to thimerosal: The sensitizing moiety. Contact Dermatitis 1996: 34: 201-203.
19. Santuccci B, Cannistraci C, Cristaudo A et al. Thimerosal positivities: the role of organomercury alkyl compounds. Contact Dermatitis 1998: 38: 325-328.